Cargando…
A Novel Inflammatory Marker for the Diagnosis of Hashimoto’s Thyroiditis: Platelet-Count-to-Lymphocyte-Count Ratio
Background: Hashimoto’s thyroiditis (HT) is a chronic autoimmune thyroiditis that causes systemic inflammation in the body, leading to hypothyroidism and an enlargement of the thyroid gland. Objectives: This study aims to reveal whether there is a relationship between Hashimoto’s thyroiditis and the...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944872/ https://www.ncbi.nlm.nih.gov/pubmed/36810529 http://dx.doi.org/10.3390/diseases11010015 |
_version_ | 1784892013273939968 |
---|---|
author | Erge, Eray Kiziltunc, Cagri Balci, Sumeyye Buse Atak Tel, Burcin Meryem Bilgin, Satilmis Duman, Tuba Taslamacioglu Aktas, Gulali |
author_facet | Erge, Eray Kiziltunc, Cagri Balci, Sumeyye Buse Atak Tel, Burcin Meryem Bilgin, Satilmis Duman, Tuba Taslamacioglu Aktas, Gulali |
author_sort | Erge, Eray |
collection | PubMed |
description | Background: Hashimoto’s thyroiditis (HT) is a chronic autoimmune thyroiditis that causes systemic inflammation in the body, leading to hypothyroidism and an enlargement of the thyroid gland. Objectives: This study aims to reveal whether there is a relationship between Hashimoto’s thyroiditis and the platelet-count-to-lymphocyte-count ratio (PLR), which is used as a new inflammatory marker. Methods: In this retrospective study, we compared the PLR of the euthyroid HT group and the hypothyroid-thyrotoxic HT group to the controls. We also evaluated the values of thyroid-stimulating hormone (TSH), free T4 (fT4), C-reactive protein (CRP), aspartate transaminase (AST), alanine transaminase (ALT), white blood cell count, lymphocyte count, hemoglobin, hematocrit, and platelet count in each group. Results: The PLR of the subjects with Hashimoto’s thyroiditis was found to be significantly different from the control group (p < 0.001), with the rankings as follows: hypothyroid-thyrotoxic HT 177% (72–417) > euthyroid HT 137% (69–272) > control group 103% (44–243). In addition to the increased PLR values, an increase in CRP values was also observed, revealing a strong positive correlation between the PLR and CRP in the HT patients. Conclusion: In this study, we found out that the PLR was higher in the hypothyroid-thyrotoxic HT and euthyroid HT patients than in a healthy control group. |
format | Online Article Text |
id | pubmed-9944872 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-99448722023-02-23 A Novel Inflammatory Marker for the Diagnosis of Hashimoto’s Thyroiditis: Platelet-Count-to-Lymphocyte-Count Ratio Erge, Eray Kiziltunc, Cagri Balci, Sumeyye Buse Atak Tel, Burcin Meryem Bilgin, Satilmis Duman, Tuba Taslamacioglu Aktas, Gulali Diseases Article Background: Hashimoto’s thyroiditis (HT) is a chronic autoimmune thyroiditis that causes systemic inflammation in the body, leading to hypothyroidism and an enlargement of the thyroid gland. Objectives: This study aims to reveal whether there is a relationship between Hashimoto’s thyroiditis and the platelet-count-to-lymphocyte-count ratio (PLR), which is used as a new inflammatory marker. Methods: In this retrospective study, we compared the PLR of the euthyroid HT group and the hypothyroid-thyrotoxic HT group to the controls. We also evaluated the values of thyroid-stimulating hormone (TSH), free T4 (fT4), C-reactive protein (CRP), aspartate transaminase (AST), alanine transaminase (ALT), white blood cell count, lymphocyte count, hemoglobin, hematocrit, and platelet count in each group. Results: The PLR of the subjects with Hashimoto’s thyroiditis was found to be significantly different from the control group (p < 0.001), with the rankings as follows: hypothyroid-thyrotoxic HT 177% (72–417) > euthyroid HT 137% (69–272) > control group 103% (44–243). In addition to the increased PLR values, an increase in CRP values was also observed, revealing a strong positive correlation between the PLR and CRP in the HT patients. Conclusion: In this study, we found out that the PLR was higher in the hypothyroid-thyrotoxic HT and euthyroid HT patients than in a healthy control group. MDPI 2023-01-22 /pmc/articles/PMC9944872/ /pubmed/36810529 http://dx.doi.org/10.3390/diseases11010015 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Erge, Eray Kiziltunc, Cagri Balci, Sumeyye Buse Atak Tel, Burcin Meryem Bilgin, Satilmis Duman, Tuba Taslamacioglu Aktas, Gulali A Novel Inflammatory Marker for the Diagnosis of Hashimoto’s Thyroiditis: Platelet-Count-to-Lymphocyte-Count Ratio |
title | A Novel Inflammatory Marker for the Diagnosis of Hashimoto’s Thyroiditis: Platelet-Count-to-Lymphocyte-Count Ratio |
title_full | A Novel Inflammatory Marker for the Diagnosis of Hashimoto’s Thyroiditis: Platelet-Count-to-Lymphocyte-Count Ratio |
title_fullStr | A Novel Inflammatory Marker for the Diagnosis of Hashimoto’s Thyroiditis: Platelet-Count-to-Lymphocyte-Count Ratio |
title_full_unstemmed | A Novel Inflammatory Marker for the Diagnosis of Hashimoto’s Thyroiditis: Platelet-Count-to-Lymphocyte-Count Ratio |
title_short | A Novel Inflammatory Marker for the Diagnosis of Hashimoto’s Thyroiditis: Platelet-Count-to-Lymphocyte-Count Ratio |
title_sort | novel inflammatory marker for the diagnosis of hashimoto’s thyroiditis: platelet-count-to-lymphocyte-count ratio |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944872/ https://www.ncbi.nlm.nih.gov/pubmed/36810529 http://dx.doi.org/10.3390/diseases11010015 |
work_keys_str_mv | AT ergeeray anovelinflammatorymarkerforthediagnosisofhashimotosthyroiditisplateletcounttolymphocytecountratio AT kiziltunccagri anovelinflammatorymarkerforthediagnosisofhashimotosthyroiditisplateletcounttolymphocytecountratio AT balcisumeyyebuse anovelinflammatorymarkerforthediagnosisofhashimotosthyroiditisplateletcounttolymphocytecountratio AT ataktelburcinmeryem anovelinflammatorymarkerforthediagnosisofhashimotosthyroiditisplateletcounttolymphocytecountratio AT bilginsatilmis anovelinflammatorymarkerforthediagnosisofhashimotosthyroiditisplateletcounttolymphocytecountratio AT dumantubataslamacioglu anovelinflammatorymarkerforthediagnosisofhashimotosthyroiditisplateletcounttolymphocytecountratio AT aktasgulali anovelinflammatorymarkerforthediagnosisofhashimotosthyroiditisplateletcounttolymphocytecountratio AT ergeeray novelinflammatorymarkerforthediagnosisofhashimotosthyroiditisplateletcounttolymphocytecountratio AT kiziltunccagri novelinflammatorymarkerforthediagnosisofhashimotosthyroiditisplateletcounttolymphocytecountratio AT balcisumeyyebuse novelinflammatorymarkerforthediagnosisofhashimotosthyroiditisplateletcounttolymphocytecountratio AT ataktelburcinmeryem novelinflammatorymarkerforthediagnosisofhashimotosthyroiditisplateletcounttolymphocytecountratio AT bilginsatilmis novelinflammatorymarkerforthediagnosisofhashimotosthyroiditisplateletcounttolymphocytecountratio AT dumantubataslamacioglu novelinflammatorymarkerforthediagnosisofhashimotosthyroiditisplateletcounttolymphocytecountratio AT aktasgulali novelinflammatorymarkerforthediagnosisofhashimotosthyroiditisplateletcounttolymphocytecountratio |